How many employees work at Revance Therapeutics?
Revance Therapeutics, Inc. has approximately 795 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Revance Therapeutics’s total headcount has declined 11.8% from 902 employees in 2023 to 795 in 2026.
Is Revance Therapeutics hiring right now?
Yes, Revance Therapeutics is actively hiring. Revance Therapeutics had 91 active job postings in 2026, a 127.9% increase from 2025 — see job openings & hiring trends.
About Revance Therapeutics’s Workforce
Revance Therapeutics, Inc. is a Pharmaceuticals company that employs 795 people worldwide as of March 2026. It is the 7th-largest by headcount among its peers. Founded in 1999, the company is headquartered in Nashville, Tennessee.
Revance Therapeutics's workforce has declined 11.8% from 2023 to 2026, down 2.2% year over year in 2026. It fell to a low of 733 in 2024 Q4 before recovering. Its workforce is concentrated most in the United States (93.9%), followed by Germany (1.4%) and the United Kingdom (0.9%), with the Netherlands, its fastest-growing location.
Revance Therapeutics's largest functional groups are Finance and Operations (44.1%), Sales and Marketing (29.5%), and Engineering (26.4%), with Finance and Operations growing fastest (up 6.8%). Median employee tenure is 2.6 years. The average salary is $155,944, ranging from a median of $137,000 in Western Europe to $104,000 in Northern Europe.
Revance Therapeutics's active job postings rose 127.9% in 2026 to 91, with new postings per month climbing from 39 in 2023 to 59 in 2026. Overall employee sentiment is neutral but improving. The Netherlands is highlighted as its fastest-growing location.
Sourced from Revelio Labs workforce data.
- Headquarters
- Nashville, Tennessee
- Founded
- 1999
- Industry
- Pharmaceuticals
- Employees
- 795
- YoY
- -2.2% (+58)
As of March 2026
Revance Therapeutics workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Revance Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsRevance Therapeutics Annual Employee Count (2023-2026)
- Revance Therapeutics had 795 employees in 2026, a 2.2% decline (+58) from 2025.
- Revance Therapeutics had 747 employees in 2025, a 8.5% decline (+14) from 2024.
- Revance Therapeutics had 733 employees in 2024, a 5.0% decline (-90) from 2023.
- Revance Therapeutics had 823 employees in 2023, a 4.4% decline (+45) from 2022.
Revance Therapeutics's total workforce has grown from 733 employees in 2024 to 795 in 2026. Revance Therapeutics's headcount peaked at 902 in 2023 before declining in 2024 and recovering through 2025 and 2026.
Revance Therapeutics, Inc. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 795 | +58 | -2.2% |
| 2025 | Q4 | 747 | +14 | -8.5% |
| 2025 | Q3 | 737 | -18 | -9.4% |
| 2025 | Q2 | 737 | -34 | -8.3% |
| 2025 | Q1 | 737 | -50 | -9.0% |
| 2024 | Q4 | 733 | -90 | -5.0% |
| 2024 | Q3 | 755 | -124 | -8.1% |
| 2024 | Q2 | 771 | -131 | -9.4% |
| 2024 | Q1 | 787 | -66 | -6.8% |
| 2023 | Q4 | 823 | +45 | -4.4% |
| 2023 | Q3 | 879 | +119 | +1.0% |
| 2023 | Q2 | 902 | +177 | +2.8% |
See Revance Therapeutics's complete headcount history, including quarterly breakdowns.
Get the DataRevance Therapeutics Employee Count by Country and Region (2026)
The United States accounts for the largest share of Revance Therapeutics's global workforce with approximately 94% of total employees, followed by Germany and the United Kingdom. Revance Therapeutics's headcount in the Netherlands is growing fastest among its major locations, up 38.6% year over year in 2026.
Revance Therapeutics employees by country
| Country | Employees | % of Total | YoY % |
|---|---|---|---|
| United States | 721 | 93.9% | +4.5% |
| Germany | 11 | 1.4% | +34.9% |
| United Kingdom | 7 | 0.9% | -10.6% |
| Canada | 5 | 0.6% | +0.5% |
| India | 4 | 0.5% | +0.0% |
| Uganda | 3 | 0.4% | +0.0% |
| Ireland | 3 | 0.4% | +0.0% |
| Netherlands | 2 | 0.3% | +38.6% |
| Italy | 2 | 0.2% | +0.0% |
| France | 2 | 0.2% | +0.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataRevance Therapeutics Employee Count by Department (2026)
Revance Therapeutics's largest employee groups are Finance and Operations (44.1%), Sales and Marketing (29.5%), and Engineering (26.4%).
Revance Therapeutics employees by department
| Department | Employees | % of Total | YoY % |
|---|---|---|---|
| Finance and Operations | 350 | 44.1% | +6.8% |
| Sales and Marketing | 234 | 29.5% | +4.0% |
| Engineering | 209 | 26.4% | +3.3% |
Compare Revance Therapeutics's department mix to industry peers.
See Full DataRevance Therapeutics Employee Salary by Region (2026)
Revance Therapeutics's average employee salary is $155,944 globally. Employees in Western Europe receive the highest compensation. Pay is lowest in Northern Europe, at a median of $104,000.
Revance Therapeutics median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Western Europe | $137,000 |
| Northern America | $128,000 |
| Northern Europe | $104,000 |
Unlock salary by role, level, and city — and compare to Revance Therapeutics's industry peers.
Unlock Salary DataRevance Therapeutics Job Openings and Hiring Trends (2023-2026)
- Revance Therapeutics had 91 active job postings in 2026, a 127.9% increase (+30) from 2025.
- Revance Therapeutics had 61 active job postings in 2025, a 129.7% increase (+48) from 2024.
- Revance Therapeutics had 13 active job postings in 2024, a 20.7% decline (-3) from 2023.
- Revance Therapeutics had 16 active job postings in 2023, a 83.6% decline from 2022.
- Hiring velocity in 2026: 59 new roles/month, up from 26 in 2025 and 23 in 2024.
Revance Therapeutics's hiring is accelerating: active job postings rose 127.9% in 2026 to 91, with new postings per month climbing from 39 in 2023 to 59 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataRevance Therapeutics Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Revance Therapeutics's workforce based on public professional data. Overall sentiment is neutral and has improved year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Frequently Asked Questions About Revance Therapeutics
- How fast is Revance Therapeutics growing?
- In 2026, Revance Therapeutics's headcount shrank 2.2% to 795 employees, up from 737 in 2025.
- Where are Revance Therapeutics employees located?
- Most Revance Therapeutics employees are based in the United States (93.9% of headcount), followed by Germany and the United Kingdom.
- What is the average salary at Revance Therapeutics?
- The average employee salary at Revance Therapeutics is approximately $155.9k per year.
- How many people does Revance Therapeutics hire per year?
- In 2026, Revance Therapeutics opened roughly 708 new roles — about 59 per month.
- When was Revance Therapeutics founded and where is it headquartered?
- Revance Therapeutics was founded in 1999 and is headquartered in Nashville, Tennessee.
Speak with a workforce expert about Revance Therapeutics.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.